Toxicology

Introduction to Toxicology of Drugs of Abuse (DOA)

  • Involves prescription, over-the-counter, or illicit drugs.

  • Applications of testing include:

    • Assisting physicians in the diagnosis and treatment of overdoses.

    • Use by governmental bodies, industrial sectors, educational institutions, sports agencies, in pregnancy assessments, for organ transplant candidates, in pain management clinics, and in drugs of abuse treatment programs.

    • Lab results must be legally admissible and defendable.

Drugs of Abuse (DOA) Testing

  • Initial step involves the screening of a single urine specimen for various substances or drug classes using qualitative procedures.

  • This can detect recent drug use.

  • Limitations:

    • Does not determine the timing of drug intake.

    • Cannot ascertain the dosage taken.

    • Cannot differentiate between casual use and chronic abuse.

  • Diagnosis of chronic abuse relies on several positive test results combined with clinical evaluation.

Rigorous Collection Scheme for Forensic DOA Testing

  • Requires:

    • Direct observation during specimen collection.

    • Limitations on personal belongings and clothing.

    • Use of tamper-proof specimen cups.

    • Tamper-evident seals on specimens.

    • Temperature strips attached to specimens.

    • Documentation of the chain of custody for specimens.

    • Security measures for specimen storage, particularly for positive samples which must be kept frozen and secure for one year.

Checking for Specimen Adulteration

  • Procedures to ensure the specimen has not been tampered with or diluted include:

    • Noting any abnormal color or odor of the urine sample.

    • Testing for:

    • Urinary temperature.

    • Specific gravity.

    • Creatinine levels.

    • pH levels.

    • Presence of nitrites.

Clinical DOA Screen Requirements

  • Minimum volume of urine required:

    • 5-10 mL, with exceptions made for children.

  • Most random urine creatinine values exceed 2.0 mmol/L.

  • For values between 1.0 - 2.0 mmol/L:

    • A comment is added recommending the collection of a new specimen while limiting fluid intake.

  • Values less than 1.0 mmol/L:

    • Testing is not performed unless the sample is from a child with small muscle mass.

2-Tiered Approach to DOA Testing

  • Initial screening tests are expected to be:

    • Simple, rapid, inexpensive, and easily automated.

    • Qualitative (spot tests) or quantitative.

    • Methods should have good sensitivity but marginal specificity, meaning it detects classes of drugs.

  • Negative results rule out exposure to a toxicant, while positive results are considered presumptive and must be confirmed.

    • Positive screening results need to be interpreted along with clinical signs/symptoms and other laboratory data due to possibilities of false positives.

  • Specimen samples generally consist of urine and are often tested via immunoassays (automated or point of care).

Confirmatory Testing in DOA

  • Confirmatory testing is required for forensic samples and might be necessary for clinical samples.

  • Methods used for confirmatory testing differ from initial screening.

  • High sensitivity and specificity are desired for these tests, which may be quantitative or qualitative.

  • Common methods include:

    • Immunoassays.

    • Chromatography (High-Performance Liquid Chromatography, LC/MS).

    • The reference method is typically Gas Chromatography-Mass Spectrometry (GC-MS), noted for its high sensitivity and specificity.

Laboratory Policies on DOA Screening

  • Laboratories involved in screening tests must set policies for managing positive screening outcomes to prevent false allegations of drug use.

  • Emphasis on the accuracy and precision of methods used.

Example: BIO RAD TOX/SEE™ Drug Screen Test

  • This test employs a lateral flow chromatographic immunoassay and tests for up to 12 drugs of abuse (DOA):

    • Amphetamines (AMP)

    • Barbiturates (BAR)

    • Benzodiazepines (BZO)

    • Cocaine (COC)

    • Marijuana (THC)

    • Methadone (MTD)

    • Methamphetamine (MET)

    • Methylenedioxymethamphetamine (MDMA)

    • Opiate (OPI)

    • Phencyclidine (PCP)

    • Tricyclic antidepressants (TCA)

BIO RAD TOX/SEE: Testing Principle

  • The mechanism is a competitive binding immunoassay where urine migrates upward via capillary action.

  • The drug-protein conjugate competes with the drug in the sample for a limited number of antibody sites immobilized on the test device.

    • If the drug is present in concentrations above the cutoff, it will occupy all antibody binding sites, preventing binding of the drug conjugate and resulting in no color change in the test region.

    • If the drug concentration is below the cutoff, there will be available antibody sites, allowing for the conjugate to bind and generate a visible colored line on the test strip.

Result Interpretation

  • Procedure:

    1. Bring the test device to room temperature.

    2. Hold the dropper vertically and transfer three full drops of urine to each specimen well, initiating a timer.

    3. Results are read after 5 minutes with the following interpretations:

    • Positive: No colored line in the test line region, with a colored line at the control line region.

    • Negative: Colored line present at both the test line and control line regions.

Example: Triage™ Drugs of Abuse Screen

  • This qualitative analysis tests for eight drugs, including:

    • Phencyclidine (PCP)

    • Benzodiazepines (BZO)

    • Cocaine (COC)

    • Amphetamines (AMP)

    • Cannabinoids (THC)

    • Opiates (OPI)

    • Barbiturates (BAR)

    • Tricyclic antidepressants (TCA)

  • A distinct color bar appears in the Drug Detection Zone indicating a positive result, although this method has lower sensitivity at low concentrations compared to routine EMIT methods.

  • Further information can be found at the linked product page.

Drugs of Abuse: Amphetamines and Methamphetamine

  • Therapeutic uses include treatment for narcolepsy and Attention Deficit Disorder (ADD).

  • Central Nervous System (CNS) stimulant effects include increased alertness, reduced fatigue, and elevated mood.

  • Progression to side effects includes restlessness, irritability, and potential psychosis.

  • High abuse potential often results in:

    • Users may mix amphetamines with opioids (e.g., a "speedball") or depressants like barbiturates or alcohol.

Side Effects of Amphetamine Use

  • Notable signs and symptoms include:

    • Specific odors, such as a cat urine smell.

    • Dental decay referred to as “meth mouth.”

    • Weight loss and elevated body temperature.

    • Psychological effects: paranoia and hallucinations (e.g., feelings of "bugs crawling").

  • In excessive use, serious outcomes include psychotic reactions, severe cardiovascular effects (e.g., tachycardia, hypertension), convulsions, and potentially death.

Amphetamine Testing

  • Can be beneficial in emergency rooms and rehabilitation programs.

  • Casual users can have detectable quantities in urine for up to 48 hours after last use.

  • Screening is typically via immunoassays, with false positives possible from over-the-counter medications such as ephedrine, pseudoephedrine, and phenylpropanolamine.

MDMA (Ecstasy)

  • MDMA is a methylenedioxymethylamphetamine and is a popular illicit drug with high abuse potential.

  • Can manifest numerous adverse effects including hallucinations, euphoria, headache, agitation, impaired memory, violent behavior, seizures, and nausea.

  • General testing methods may give negative results; clinical history and symptoms are used by doctors, with confirmatory testing typically by GC-MS.

Cannabinoids (Marijuana)

  • Cannabis is derived from the flowering tops and leaves of hemp plants (processed form is hashish).

  • Common effects: euphoria, relaxation, short-term memory loss, and impairment in intellectual and psychomotor tasks.

  • THC (delta-9-tetrahydrocannabinol) is the most potent and abundant cannabinoid compound.

  • Liver metabolism generates several components, with the major urine metabolite being 11-nor-Δ-tetrahydrocannabinol-9-carboxylic acid (THC-COOH), which is commonly detected in cannabinoid assays.

Value of THC Testing in Clinical Settings

  • Casual users can have detectable THC-COOH in urine for 3-5 days after last use; chronic users can test positive 3-4 weeks after abstinence, with some cases showing positivity up to 12 weeks later.

  • Confirmatory testing via GC-MS is preferred.

Cocaine Overview

  • Cocaine originates from the Erythroxylon tree leaves and is extracted to form cocaine hydrochloride (“snow”).

  • Free-base form, referred to as “crack,” can be vaporized for inhalation.

  • Cocaine is a potent stimulant known to be highly addictive and harmful.

  • Acute toxicity can lead to hypertension, arrhythmias, seizures, and even myocardial infarction or death.

Cocaine Testing

  • The half-life of cocaine is approximately 0.5 - 1 hour due to rapid hepatic hydrolysis, thus multiple doses are needed for effect, with only a small portion detectable in urine.

  • The major metabolite, benzoylecgonine, is sensitive and specific as a marker of cocaine use.

  • Casual users will have detectable levels in urine for up to three days, while heavy chronic abusers can test positive for up to twenty days post-use.

Opiates Overview

  • Opiates are derived from the opium poppy, including morphine, codeine, and semi-synthetic forms like heroin, and methadone.

  • Classified as therapeutics for analgesia and sedation, but have high abuse potential leading to psychological and physical dependence.

Opiate Testing

  • Testing for opiates is crucial in emergency settings and rehabilitation.

  • Detectable quantities can be present in urine for up to 48 hours after use.

  • Immunoassay screens are designed primarily to detect morphine and codeine, with cross-reactivity issues complicating interpretations of results.

Methadone Details

  • A synthetic narcotic related to morphine and heroin.

  • Used primarily to treat heroin addiction and as an analgesic.

Phencyclidine (PCP)

  • PCP possesses stimulant, anesthetic, depressant, and hallucinogenic properties.

  • Originally a medicinal anesthetic, now high in misuse potential, leading to unpredictable behavioral changes and stimulant effects.

  • Testing in urine is utilized in clinical settings and typically confirmed by GC-MS.

Notes on Testing for PCP

  • Detection can vary from 48 hours for casual users up to 30 days for chronic users.

Anabolic Steroids

  • Are synthetic derivatives of testosterone, used to increase muscle mass.

  • Associated with a range of health risks including toxic hepatitis and cardiovascular issues.

Notes on Testosterone Testing

  • Chronic use can lead to testicular atrophy and sterility in biological males, while females may experience masculinization effects.

  • Testing primarily involves measuring parent compounds and their metabolites through methodologies like gas chromatography-mass spectrometry (GC-MS).

Community Context of Toxicology

  • Clinical labs must be knowledgeable about the drugs found in their patient population, which includes consultation on specific drugs like Dilaudid and Oxycontin.

Toxicology of Metals

  • Techniques such as Atomic Absorption Spectrophotometry (AAS) and Inductively Coupled Plasma Mass Spectrometry (ICP-MS) are used for detecting metals such as arsenic, lead, cadmium, and mercury.

Arsenic Exposure and Toxicity

  • Arsenic exposure can occur through food, air, water, and industrial settings.

  • Toxicity varies by form and can lead to cumulative effects with low-level exposure resulting in non-specific symptoms, while high levels affect multiple organ systems.

Lead Exposure and Its Effects

  • Lead can be found in paints and plumbing, particularly before 1972, with a notable effect of higher absorption rates in children leading to serious developmental issues.

Cadmium Characteristics

  • Commonly found in various industrial applications, cadmium binds to proteins and causes significant toxic effects, primarily to kidneys.

Mercury Toxicology

  • Mercury exposure is widespread, especially through contaminated food sources, leading to various toxic symptoms depending on the form encountered.

Pesticide Toxicology

  • Pesticides can cause severe poisoning; organophosphates are a key concern due to their potential for significant adverse effects.

Cyanide Toxicity

  • Cyanide exposure has widespread industrial applications and can lead to rapid and severe toxicity.

Pediatric Drug Services

  • Pediatric toxicology includes considerations for accidental poisonings and substance abuse issues in children, closely mirroring adult toxicology services.

Reference Intervals for Toxicology Tests

  • Various substances have specific reference intervals and limits categorizing their toxicological significance.

Conclusion

  • It is crucial for clinical labs to thoroughly understand toxicology, testing methods, and the implications of results to provide accurate diagnoses and treatment plans.